Carbamazepine

ArticlesMedicine Compliance Aid StabilityLactation Safety Information ·
40820003

Articles

Medicine Compliance Aid Stability

TegretolNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Tegretol
Tablets 100mg, 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
9 February 2015

Tegretol prolonged releaseNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Tegretol prolonged release
Tablets m/r 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
9 February 2015

TegretolNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Tegretol
Chewtabs 100mg, 200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
9 February 2015

genericNon-proprietary

Non-proprietary
generic
Tablets 100mg, 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
9 February 2015

Carbagen SRGenerics UK Ltd

Generics UK Ltd
Carbagen SR
Tablets f/c m/r 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
9 February 2015

Lactation Safety Information

For bipolar disorder

For bipolar disorder
Appropriate second generation antipsychotic
Significant published evidence of use in breastfeeding
Significant amounts in breast milk
Case reports of sedation, poor suckling, withdrawal reactions, and hepatic dysfunction reported in infants exposed to carbamazepine via breast milk
Monitor infant for signs of sedation, poor feeding ad liver dysfunction
3 January 2018

Oral / Rectal For epilepsy

Oral / Rectal
For epilepsy
Suitable alternative antiepileptic
Significant published evidence of use in breastfeeding
Relatively high, but subtherapeutic, amounts in breast milk
Case reports of sedation, poor suckling, regurgitation with vomiting, withdrawal reactions, and hepatic dysfunction in infants exposed to carbamazepine via breast milk
Monitor infant for GI symptoms and signs of liver dysfunction
18 September 2018